Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer

Description

The purpose of this study is to enhance the care of older metastatic gastric cancer (mGC) patients by increasing awareness among oncology providers of the unique aspects of care required for older patients. The goal of the study is to educate providers on the utility of geriatric assessment in guiding therapy of older mGC patients. The investigators will also assess the feasibility and benefit of incorporating geriatric self-assessments into clinical practice. The study will include four phases.

Conditions

Metastatic Gastric Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to enhance the care of older metastatic gastric cancer (mGC) patients by increasing awareness among oncology providers of the unique aspects of care required for older patients. The goal of the study is to educate providers on the utility of geriatric assessment in guiding therapy of older mGC patients. The investigators will also assess the feasibility and benefit of incorporating geriatric self-assessments into clinical practice. The study will include four phases.

Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer

Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer

Condition
Metastatic Gastric Cancer
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States, 19111

Philadelphia

Temple University Hospital, Philadelphia, Pennsylvania, United States, 19140

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Ability to read and understand English, ability to sign consent, and complete a self-assessment evaluation.
  • 2. Evidence of mGC (mGE junction cancer allowed). Patients can be enrolled at any stage of their treatment or disease course.
  • 3. Ongoing active therapy for mGC. Patients can be treated with any type of therapy including chemotherapy, immunotherapy or Her-2 targeted therapy.
  • 4. Life expectancy ≥3 months.
  • 1. ≤69 years old.
  • 2. Inability to read and understand English.
  • 3. No evidence of mGC.
  • 4. Not on active therapy.
  • 5. Life expectancy \<3 months.

Ages Eligible for Study

70 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Fox Chase Cancer Center,

Study Record Dates

2023-12-31